The global custom antibody market size is expected to reach USD 301.7 million by 2030, expanding at a CAGR of 9.7% from 2023 to 2030. The market is expected to witness substantial growth during the forecast period. This growth is attributed to the increasing fundraising by biotech startups for developing innovative products. Additionally, rising awareness of personalized diagnostic and therapeutic treatments in emerging markets is also a contributing factor to the growth of the custom antibody market.
Increasing investment by the players to expand their services in the development and production of antibodies is likely to support the growth of the market. For instance, Absolute Antibody Ltd. is into the services of custom antibody sequencing, expression, and engineering. In August 2022, the company announced the expansion of its manufacturing facility by increasing the lab space and investing in automated technology such as next-generation sequencing, purification, and expression. The expansion is expected to improve the production workflow for recombinant antibodies.
Similarly, companies are also improving the application of custom antibodies. According to an article published in January 2023, MilliporeSigma is planning to develop new antibodies through its Cell Marque Tissue Diagnostics technology. The rabbit polyclonal antibody is customized to detect a type of glioma, ATRX. Gliomas account for 30% of tumors in the central nervous system. Through this antibody, the company is anticipated to expand its portfolio in neuropathology.
Monetary support to academic and research institutions through grants from regulatory bodies and discount offers on services by companies are anticipated to enhance custom antibody discovery and research during the forecast period. For instance, Absolute antibody offers 10% off on custom services, while a similar discount is also offered by AltaBioscience for a limited time period. The discounts are expected to reduce the overall cost of production for researchers.
However, the high cost of producing custom monoclonal antibodies is expected to restrain the growth of the custom antibody market. The average estimated cost is around USD 6,000 to 15,000. The cost acts as a market entry barrier for various startups and emerging players. However, the cost can be reduced by developing reliable production reagents and techniques to avoid the upfront cost.
Increasing investment by the players to expand their services in the development and production of antibodies is likely to support the growth of the market. For instance, Absolute Antibody Ltd. is into the services of custom antibody sequencing, expression, and engineering. In August 2022, the company announced the expansion of its manufacturing facility by increasing the lab space and investing in automated technology such as next-generation sequencing, purification, and expression. The expansion is expected to improve the production workflow for recombinant antibodies.
Similarly, companies are also improving the application of custom antibodies. According to an article published in January 2023, MilliporeSigma is planning to develop new antibodies through its Cell Marque Tissue Diagnostics technology. The rabbit polyclonal antibody is customized to detect a type of glioma, ATRX. Gliomas account for 30% of tumors in the central nervous system. Through this antibody, the company is anticipated to expand its portfolio in neuropathology.
Monetary support to academic and research institutions through grants from regulatory bodies and discount offers on services by companies are anticipated to enhance custom antibody discovery and research during the forecast period. For instance, Absolute antibody offers 10% off on custom services, while a similar discount is also offered by AltaBioscience for a limited time period. The discounts are expected to reduce the overall cost of production for researchers.
However, the high cost of producing custom monoclonal antibodies is expected to restrain the growth of the custom antibody market. The average estimated cost is around USD 6,000 to 15,000. The cost acts as a market entry barrier for various startups and emerging players. However, the cost can be reduced by developing reliable production reagents and techniques to avoid the upfront cost.
Custom Antibody Market Report Highlights
- By type, the monoclonal antibody segment is considered to be a relatively more mature and dominant segment than polyclonal in 2022. The increasing R&D investment by companies is expected to support the growth of the custom antibody market
- By service, the antibody development segment captured the majority of the custom antibody market share in 2022. The number and type of players in this service segment are greater than antibody production and fragmentation, which is contributing to the growth
- By source, the mice segment is estimated to be the fastest-growing during the forecast period. This is because mice are widely available lab animals and can be easily used for custom antibody production
- By application, infectious disease is considered the key segment with the largest market share in 2022, and this trend is likely to be maintained over the forecast period. This growth can be attributed to the emerging infectious diseases in developing countries
- By end-users, the academic and research institutions segment is estimated to be the fastest-growing segment, with the largest market share in 2022. The growth is attributed to the increasing grants and financial assistance from governments and companies
- North America has established a strong regional position in the market with 44.91% of the overall market share in 2022. The increasing incidence rate of cancer and high R&D expenditure are encouraging companies to undertake product development in the region
Table of Contents
Chapter 1. Methodology and Scope1.1. Information Procurement
1.2. Information or Data Analysis
1.3. Market Scope & Segment Definition
1.4. Market Model
1.4.1. Market Study, By Company Market Share
1.4.2. Regional Analysis
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Segmentation and Scope
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Trends and Outlook
3.4. Market Dynamics
3.4.1. Increasing demand for customized diagnostics and therapeutics
3.4.2. Ease of collaboration and partnerships amongst players
3.4.3. Increasing initiatives by the regulatory bodies
3.5. Market Restraint Analysis
3.5.1. High cost of production
3.6. Penetration and Growth Prospect Mapping 2022
3.7. Business Environment Analysis
3.7.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
3.7.2. Porter’s Five Forces Analysis
3.8. COVID-19 Impact Analysis
Chapter 4. Type Business Analysis
4.1. Custom Antibody Market: Type Movement Analysis
4.2. Monoclonal Antibodies
4.2.1. Monoclonal Antibodies Market, 2018 - 2030 (USD Million)
4.3. Polyclonal Antibodies
4.3.1. Polyclonal Antibodies Market, 2018 - 2030 (USD Million)
4.4. Recombinant Antibodies
4.4.1. Recombinant Antibodies Market, 2018 - 2030 (USD Million)
4.5. Others
4.5.1. Others Market, 2018 - 2030 (USD Million)
Chapter 5. Service Business Analysis
5.1. Custom Antibody Market: Service Movement Analysis
5.2. Antibody Development
5.2.1. Antibody Development Market, 2018 - 2030 (USD Million)
5.3. Antibody Production & Purification
5.3.1. Antibody Production & Purification Market, 2018 - 2030 (USD Million)
5.4. Antibody Fragmentation & Labelling
5.4.1. Antibody Fragmentation & Labelling Market, 2018 - 2030 (USD Million)
Chapter 6. Source Business Analysis
6.1. Custom Antibody Market: Source Movement Analysis
6.2. Mice
6.2.1. Mice Market, 2018 - 2030 (USD Million)
6.3. Rabbit
6.3.1. Rabbit Market, 2018 - 2030 (USD Million)
6.4. Others
6.4.1. Others Market, 2018 - 2030 (USD Million)
Chapter 7. Application Business Analysis
7.1. Custom Antibody Market: Application Movement Analysis
7.2. Oncology
7.2.1. Oncology Market, 2018 - 2030 (USD Million)
7.3. Infectious Diseases
7.3.1. Infectious Diseases Market, 2018 - 2030 (USD Million)
7.4. Neurology
7.4.1. Neurology Market, 2018 - 2030 (USD Million)
7.5. Stem cells
7.5.1. Stem cells Market, 2018 - 2030 (USD Million)
7.6. Immunology
7.6.1. Immunology Market, 2018 - 2030 (USD Million)
7.7. Cardiovascular Diseases
7.7.1. Cardiovascular Diseases Market, 2018 - 2030 (USD Million)
7.8. Others
7.8.1. Others Market, 2018 - 2030 (USD Million)
Chapter 8. End-user Business Analysis
8.1. Custom Antibody Market: End-user Movement Analysis
8.2. Pharmaceutical & Biotechnology Companies
8.2.1. Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
8.3. Academic & Research Institutes
8.3.1. Academic & Research Institutes Market, 2018 - 2030 (USD Million)
8.4. CRO
8.4.1. CRO Market, 2018 - 2030 (USD Million)
8.5. Hospitals and Clinics
8.5.1. Hospitals and Clinics Market, 2018 - 2030 (USD Million)
Chapter 9. Regional Business Analysis
9.1. Custom Antibody Market Share By Region, 2022 & 2030
9.2. North America
9.2.1. SWOT Analysis
9.2.2. North America Custom Antibody Market, 2018 - 2030 (USD Million)
9.2.3. U.S.
9.2.3.1. Key Country Dynamics
9.2.3.2. Target Disease Prevalence
9.2.3.3. Competitive Scenario
9.2.3.4. Regulatory Framework
9.2.3.5. Reimbursement Scenario
9.2.3.6. U.S. Custom Antibody Market, 2018 - 2030 (USD MILLION)
9.2.4. Canada
9.2.4.1. Key Country Dynamics
9.2.4.2. Target Disease Prevalence
9.2.4.3. Competitive Scenario
9.2.4.4. Regulatory Framework
9.2.4.5. Reimbursement Scenario
9.2.4.6. Canada Custom Antibody Market, 2018 - 2030 (USD Million)
9.3. Europe
9.3.1. SWOT Analysis
9.3.2. Europe Custom Antibody Market, 2018 - 2030 (USD Million)
9.3.3. Germany
9.3.3.1. Key Country Dynamics
9.3.3.2. Target Disease Prevalence
9.3.3.3. Competitive Scenario
9.3.3.4. Regulatory Framework
9.3.3.5. Reimbursement Scenario
9.3.3.6. Germany Custom Antibody Market, 2018 - 2030 (USD Million)
9.3.4. UK
9.3.4.1. Key Country Dynamics
9.3.4.2. Target Disease Prevalence
9.3.4.3. Competitive Scenario
9.3.4.4. Regulatory Framework
9.3.4.5. Reimbursement Scenario
9.3.4.6. UK Custom Antibody Market, 2018 - 2030 (USD Million)
9.3.5. France
9.3.5.1. Key Country Dynamics
9.3.5.2. Target Disease Prevalence
9.3.5.3. Competitive Scenario
9.3.5.4. Regulatory Framework
9.3.5.5. Reimbursement Scenario
9.3.5.6. France Custom Antibody Market, 2018 - 2030 (USD Million)
9.3.6. Italy
9.3.6.1. Key Country Dynamics
9.3.6.2. Target Disease Prevalence
9.3.6.3. Competitive Scenario
9.3.6.4. Regulatory Framework
9.3.6.5. Reimbursement Scenario
9.3.6.6. Italy Custom Antibody Market, 2018 - 2030 (USD Million)
9.3.7. Spain
9.3.7.1. Key Country Dynamics
9.3.7.2. Target Disease Prevalence
9.3.7.3. Competitive Scenario
9.3.7.4. Regulatory Framework
9.3.7.5. Reimbursement Scenario
9.3.7.6. Spain Custom Antibody Market, 2018 - 2030 (USD Million)
9.3.8. Denmark
9.3.8.1. Key Country Dynamics
9.3.8.2. Target Disease Prevalence
9.3.8.3. Competitive Scenario
9.3.8.4. Regulatory Framework
9.3.8.5. Reimbursement Scenario
9.3.8.6. Denmark Custom Antibody Market, 2018 - 2030 (USD Million)
9.3.9. Sweden
9.3.9.1. Key Country Dynamics
9.3.9.2. Target Disease Prevalence
9.3.9.3. Competitive Scenario
9.3.9.4. Regulatory Framework
9.3.9.5. Reimbursement Scenario
9.3.9.6. Sweden Custom Antibody Market, 2018 - 2030 (USD Million)
9.3.10. Norway
9.3.10.1. Key Country Dynamics
9.3.10.2. Target Disease Prevalence
9.3.10.3. Competitive Scenario
9.3.10.4. Regulatory Framework
9.3.10.5. Reimbursement Scenario
9.3.10.6. Norway Custom Antibody Market, 2018 - 2030 (USD Million)
9.4. Asia Pacific
9.4.1. SWOT Analysis
9.4.2. Asia Pacific Custom Antibody Market, 2018 - 2030 (USD Million)
9.4.3. Japan
9.4.3.1. Key Country Dynamics
9.4.3.2. Target Disease Prevalence
9.4.3.3. Competitive Scenario
9.4.3.4. Regulatory Framework
9.4.3.5. Reimbursement Scenario
9.4.3.6. Japan Custom Antibody Market, 2018 - 2030 (USD Million)
9.4.4. China
9.4.4.1. Key Country Dynamics
9.4.4.2. Target Disease Prevalence
9.4.4.3. Competitive Scenario
9.4.4.4. Regulatory Framework
9.4.4.5. Reimbursement Scenario
9.4.4.6. China Custom Antibody Market, 2018 - 2030 (USD Million)
9.4.5. India
9.4.5.1. Key Country Dynamics
9.4.5.2. Target Disease Prevalence
9.4.5.3. Competitive Scenario
9.4.5.4. Regulatory Framework
9.4.5.5. Reimbursement Scenario
9.4.5.6. India Custom Antibody Market, 2018 - 2030 (USD Million)
9.4.6. South Korea
9.4.6.1. Key Country Dynamics
9.4.6.2. Target Disease Prevalence
9.4.6.3. Competitive Scenario
9.4.6.4. Regulatory Framework
9.4.6.5. Reimbursement Scenario
9.4.6.6. South Korea Custom Antibody Market, 2018 - 2030 (USD Million)
9.4.7. Australia
9.4.7.1. Key Country Dynamics
9.4.7.2. Target Disease Prevalence
9.4.7.3. Competitive Scenario
9.4.7.4. Regulatory Framework
9.4.7.5. Reimbursement Scenario
9.4.7.6. Australia Custom Antibody Market, 2018 - 2030 (USD Million)
9.4.8. Thailand
9.4.8.1. Key Country Dynamics
9.4.8.2. Target Disease Prevalence
9.4.8.3. Competitive Scenario
9.4.8.4. Regulatory Framework
9.4.8.5. Reimbursement Scenario
9.4.8.6. Thailand Custom Antibody Market, 2018 - 2030 (USD Million)
9.5. Latin America
9.5.1. SWOT Analysis
9.5.2. Latin America Custom Antibody Market, 2018 - 2030 (USD Million)
9.5.3. Brazil
9.5.3.1. Key Country Dynamics
9.5.3.2. Target Disease Prevalence
9.5.3.3. Competitive Scenario
9.5.3.4. Regulatory Framework
9.5.3.5. Reimbursement Scenario
9.5.3.6. Brazil Custom Antibody Market, 2018 - 2030 (USD Million)
9.5.4. Mexico
9.5.4.1. Key Country Dynamics
9.5.4.2. Target Disease Prevalence
9.5.4.3. Competitive Scenario
9.5.4.4. Regulatory Framework
9.5.4.5. Reimbursement Scenario
9.5.4.6. Mexico Custom Antibody Market, 2018 - 2030 (USD Million)
9.5.5. Argentina
9.5.5.1. Key Country Dynamics
9.5.5.2. Target Disease Prevalence
9.5.5.3. Competitive Scenario
9.5.5.4. Regulatory Framework
9.5.5.5. Reimbursement Scenario
9.5.5.6. Argentina Custom Antibody Market, 2018 - 2030 (USD Million)
9.6. MEA
9.6.1. SWOT Analysis
9.6.2. MEA Custom Antibody Market, 2018 - 2030 (USD Million)
9.6.3. South Africa
9.6.3.1. Key Country Dynamics
9.6.3.2. Target Disease Prevalence
9.6.3.3. Competitive Scenario
9.6.3.4. Regulatory Framework
9.6.3.5. Reimbursement Scenario
9.6.3.6. South Africa Custom Antibody Market, 2018 - 2030 (USD Million)
9.6.4. Saudi Arabia
9.6.4.1. Key Country Dynamics
9.6.4.2. Target Disease Prevalence
9.6.4.3. Competitive Scenario
9.6.4.4. Regulatory Framework
9.6.4.5. Reimbursement Scenario
9.6.4.6. Saudi Arabia Custom Antibody Market, 2018 - 2030 (USD Million)
9.6.5. UAE
9.6.5.1. Key Country Dynamics
9.6.5.2. Target Disease Prevalence
9.6.5.3. Competitive Scenario
9.6.5.4. Regulatory Framework
9.6.5.5. Reimbursement Scenario
9.6.5.6. UAE Custom Antibody Market, 2018 - 2030 (USD Million)
9.6.6. Kuwait
9.6.6.1. Key Country Dynamics
9.6.6.2. Target Disease Prevalence
9.6.6.3. Competitive Scenario
9.6.6.4. Regulatory Framework
9.6.6.5. Reimbursement Scenario
9.6.6.6. Kuwait Custom Antibody Market, 2018 - 2030 (USD Million)
Chapter 10. Competitive Landscape
10.1. Participant’s overview
10.1.1. Thermo Fisher Scientific Inc.
10.1.2. Creative Diagnostics
10.1.3. Abcam plc
10.1.4. Bio-Rad Laboratories, Inc
10.1.5. Kaneka Eurogentec S.A.
10.1.6. YenZym Antibodies, LLC.
10.1.7. Abmart
10.1.8. Labcorp Drug Development
10.1.9. LifeSpan BioSciences, Inc
10.1.10. GenScript
10.2. Financial performance
10.3. Participant categorization
10.3.1. Market Leaders
10.3.2. Custom Antibody Market Share Analysis, 2022
10.3.3. Strategy Mapping
10.3.3.1. Expansion
10.3.3.2. Acquisition
10.3.3.3. Collaborations
10.3.3.4. Product/Service Launch
10.3.3.5. Partnerships
10.3.3.6. Others
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
Table 4 Global Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
Table 5 Global Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
Table 6 Global Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
Table 7 Global Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
Table 8 Global Custom Antibody Market, by Region, 2018 - 2030 (USD Million)
Table 9 North America Custom Antibody Market, by Country, 2018 - 2030 (USD Million)
Table 10 North America Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
Table 11 North America Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
Table 12 North America Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
Table 13 North America Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
Table 14 North America Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
Table 15 U.S. Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
Table 16 U.S. Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
Table 17 U.S. Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
Table 18 U.S. Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
Table 19 U.S. Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
Table 20 Canada Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
Table 21 Canada Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
Table 22 Canada Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
Table 23 Canada Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
Table 24 Canada Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
Table 25 Europe Custom Antibody Market, by Country, 2018 - 2030 (USD Million)
Table 26 Europe Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
Table 27 Europe Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
Table 28 Europe Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
Table 29 Europe Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
Table 30 Europe Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
Table 31 Germany Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
Table 32 Germany Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
Table 33 Germany Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
Table 34 Germany Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
Table 35 Germany Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
Table 36 UK Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
Table 37 UK Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
Table 38 UK Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
Table 39 UK Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
Table 40 UK Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
Table 41 France Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
Table 42 France Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
Table 43 France Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
Table 44 France Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
Table 45 France Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
Table 46 Italy Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
Table 47 Italy Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
Table 48 Italy Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
Table 49 Italy Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
Table 50 Italy Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
Table 51 Spain Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
Table 52 Spain Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
Table 53 Spain Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
Table 54 Spain Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
Table 55 Spain Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
Table 56 Denmark Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
Table 57 Denmark Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
Table 58 Denmark Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
Table 59 Denmark Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
Table 60 Denmark Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
Table 61 Sweden Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
Table 62 Sweden Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
Table 63 Sweden Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
Table 64 Sweden Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
Table 65 Sweden Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
Table 66 Norway Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
Table 67 Norway Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
Table 68 Norway Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
Table 69 Norway Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
Table 70 Norway Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
Table 71 Asia Pacific Custom Antibody Market, by Country, 2018 - 2030 (USD Million)
Table 72 Asia Pacific Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
Table 73 Asia Pacific Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
Table 74 Asia Pacific Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
Table 75 Asia Pacific Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
Table 76 Asia Pacific Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
Table 77 China Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
Table 78 China Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
Table 79 China Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
Table 80 China Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
Table 81 China Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
Table 82 Japan Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
Table 83 Japan Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
Table 84 Japan Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
Table 85 Japan Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
Table 86 Japan Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
Table 87 India Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
Table 88 India Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
Table 89 India Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
Table 90 India Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
Table 91 India Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
Table 92 South Korea Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
Table 93 South Korea Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
Table 94 South Korea Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
Table 95 South Korea Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
Table 96 South Korea Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
Table 97 Australia Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
Table 98 Australia Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
Table 99 Australia Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
Table 100 Australia Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
Table 101 Australia Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
Table 102 Thailand Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
Table 103 Thailand Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
Table 104 Thailand Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
Table 105 Thailand Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
Table 106 Thailand Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
Table 107 Latin America Custom Antibody Market, by Country, 2018 - 2030 (USD Million)
Table 108 Latin America Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
Table 109 Latin America Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
Table 110 Latin America Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
Table 111 Latin America Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
Table 112 Latin America Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
Table 113 Brazil Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
Table 114 Brazil Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
Table 115 Brazil Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
Table 116 Brazil Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
Table 117 Brazil Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
Table 118 Mexico Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
Table 119 Mexico Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
Table 120 Mexico Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
Table 121 Mexico Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
Table 122 Mexico Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
Table 123 Argentina Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
Table 124 Argentina Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
Table 125 Argentina Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
Table 126 Argentina Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
Table 127 Argentina Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
Table 128 Middle East & Africa Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
Table 129 Middle East & Africa Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
Table 130 Middle East & Africa Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
Table 131 Middle East & Africa Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
Table 132 Middle East & Africa Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
Table 133 Middle East & Africa Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
Table 134 South Africa Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
Table 135 South Africa Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
Table 136 South Africa Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
Table 137 South Africa Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
Table 138 South Africa Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
Table 139 Saudi Arabia Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
Table 140 Saudi Arabia Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
Table 141 Saudi Arabia Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
Table 142 Saudi Arabia Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
Table 143 Saudi Arabia Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
Table 144 UAE Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
Table 145 UAE Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
Table 146 UAE Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
Table 147 UAE Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
Table 148 UAE Custom Antibody Market, by Type, 2018 - 2030 (USD Million)
Table 149 Kuwait Custom Antibody Market, by Service, 2018 - 2030 (USD Million)
Table 150 Kuwait Custom Antibody Market, by Source, 2018 - 2030 (USD Million)
Table 151 Kuwait Custom Antibody Market, by Application, 2018 - 2030 (USD Million)
Table 152 Kuwait Custom Antibody Market, by End-user, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Information Procurement
Fig. 3 Primary Research Pattern
Fig. 4 Market Research Approaches
Fig. 5 Value Chain-Based Sizing & Forecasting
Fig. 6 Market Formulation & Validation
Fig. 7 Custom Antibody Market Segmentation
Fig. 8 Market Snapshot, 2022
Fig. 9 Market Trends & Outlook
Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 14 Porter’s Five Forces Analysis
Fig. 15 Market Penetration Vs Growth Prospect Mapping, 2022
Fig. 16 Global Custom Antibody Market: Type Movement Analysis
Fig. 17 Global Custom Antibody Market, for Monoclonal antibodies, 2018 - 2030 (USD Million)
Fig. 18 Global Custom Antibody Market, for Polyclonal Antibodies, 2018 - 2030 (USD Million)
Fig. 19 Global Custom Antibody Market, for Recombinant Antibodies, 2018 - 2030 (USD Million)
Fig. 20 Global Custom Antibody Market, for Others, 2018 - 2030 (USD Million)
Fig. 21 Global Custom Antibody Market: Service Movement Analysis
Fig. 22 Global Custom Antibody Market, for Antibody development, 2018 - 2030 (USD Million)
Fig. 23 Global Custom Antibody Market, for Antibody production & Purification, 2018 - 2030 (USD Million)
Fig. 24 Global Custom Antibody Market, for Antibody Fragmentation & labelling, 2018 - 2030 (USD Million)
Fig. 25 Global Custom Antibody Market: Source Movement Analysis
Fig. 26 Global Custom Antibody Market, for Mice, 2018 - 2030 (USD Million)
Fig. 27 Global Custom Antibody Market, for Rabbit, 2018 - 2030 (USD Million)
Fig. 28 Global Custom Antibody Market, for Others, 2018 - 2030 (USD Million)
Fig. 29 Global Custom Antibody Market: Application Movement Analysis
Fig. 30 Global Custom Antibody Market, for Oncology, 2018 - 2030 (USD Million)
Fig. 31 Global Custom Antibody Market, for Infectious Diseases, 2018 - 2030 (USD Million)
Fig. 32 Global Custom Antibody Market, for Neurology, 2018 - 2030 (USD Million)
Fig. 33 Global Custom Antibody Market, for Stem cells, 2018 - 2030 (USD Million)
Fig. 34 Global Custom Antibody Market, for Immunology, 2018 - 2030 (USD Million)
Fig. 35 Global Custom Antibody Market, for Cardiovascular Diseases, 2018 - 2030 (USD Million)
Fig. 36 Global Custom Antibody Market, for Others, 2018 - 2030 (USD Million)
Fig. 37 Global Custom Antibody Market: End-user Movement Analysis
Fig. 38 Global Custom Antibody Market, for Pharmaceutical & Biotechnology Companies, 2018 - 2030 (USD Million)
Fig. 39 Global Custom Antibody Market, for Academic & Research Institutes, 2018 - 2030 (USD Million)
Fig. 40 Global Custom Antibody Market, for CRO, 2018 - 2030 (USD Million)
Fig. 41 Global Custom Antibody Market, for Hospitals and Clinics, 2018 - 2030 (USD Million)
Fig. 42 Regional Marketplace: Key Takeaways
Fig. 43 Regional Outlook, 2022 & 2030
Fig. 44 Global Custom Antibody Market: Region Movement Analysis
Fig. 45 North America Custom Antibody Market, 2018 - 2030 (USD Million)
Fig. 46 U.S. Custom Antibody Market, 2018 - 2030 (USD Million)
Fig. 47 Canada Custom Antibody Market, 2018 - 2030 (USD Million)
Fig. 48 Europe Custom Antibody Market, 2018 - 2030 (USD Million)
Fig. 49 Germany Custom Antibody Market, 2018 - 2030 (USD Million)
Fig. 50 UK Custom Antibody Market, 2018 - 2030 (USD Million)
Fig. 51 France Custom Antibody Market, 2018 - 2030 (USD Million)
Fig. 52 Italy Custom Antibody Market, 2018 - 2030 (USD Million)
Fig. 53 Spain Custom Antibody Market, 2018 - 2030 (USD Million)
Fig. 54 Denmark Custom Antibody Market, 2018 - 2030 (USD Million)
Fig. 55 Sweden Custom Antibody Market, 2018 - 2030 (USD Million)
Fig. 56 Norway Custom Antibody Market, 2018 - 2030 (USD Million)
Fig. 57 Asia Pacific Custom Antibody Market, 2018 - 2030 (USD Million)
Fig. 58 Japan Custom Antibody Market, 2018 - 2030 (USD Million)
Fig. 59 China Custom Antibody Market, 2018 - 2030 (USD Million)
Fig. 60 India Custom Antibody Market, 2018 - 2030 (USD Million)
Fig. 61 Australia Custom Antibody Market, 2018 - 2030 (USD Million)
Fig. 62 South Korea Custom Antibody Market, 2018 - 2030 (USD Million)
Fig. 63 Thailand Custom Antibody Market, 2018 - 2030 (USD Million)
Fig. 64 Latin America Custom Antibody Market, 2018 - 2030 (USD Million)
Fig. 65 Brazil Custom Antibody Market, 2018 - 2030 (USD Million)
Fig. 66 Mexico Custom Antibody Market, 2018 - 2030 (USD Million)
Fig. 67 Argentina Custom Antibody Market, 2018 - 2030 (USD Million)
Fig. 68 Middle East and Africa Custom Antibody Market, 2018 - 2030 (USD Million)
Fig. 69 South Africa Custom Antibody Market, 2018 - 2030 (USD Million)
Fig. 70 Saudi Arabia Custom Antibody Market, 2018 - 2030 (USD Million)
Fig. 71 UAE Custom Antibody Market, 2018 - 2030 (USD Million)
Fig. 72 Kuwait Custom Antibody Market, 2018 - 2030 (USD Million)
Companies Mentioned
- Thermo Fisher Scientific Inc.
- Creative Diagnostics
- Abcam plc
- Bio-Rad Laboratories, Inc
- Kaneka Eurogentec S.A.
- YenZym Antibodies, LLC.
- Abmart
- Labcorp Drug Development
- LifeSpan BioSciences, Inc
- GenScript
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 180 |
| Published | February 2023 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 147.6 Million |
| Forecasted Market Value ( USD | $ 301.7 Million |
| Compound Annual Growth Rate | 9.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
